Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX7101 in POAG or OHT
NCT01528111Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Mar 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LX7101 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Lexicon Pharmaceuticals, Inc.. Started Mar 2012; status: completed.
02
Drugs
LX7101
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01528111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528111.